Wenjuan Zhang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Brain Metastases

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jianxiang Ji, Sonja Dragojevic, Cameron M Callaghan, Emily J Smith, Surabhi Talele, Wenjuan Zhang, Margaret A Connors, Ann C Mladek, Zeng Hu, Katrina K Bakken, Paige P Sarkaria, Brett L Carlson, Danielle M Burgenske, Paul A Decker, Mohammad Abdur Rashid, Mi-Hyeon Jang, Shiv K Gupta, Jeanette E Eckel-Passow, William F Elmquist, Jann N Sarkaria
Differential distribution of the DNA-PKcs inhibitor peposertib selectively radiosensitizes patient-derived melanoma brain metastasis xenografts. Molecular cancer therapeutics (2024)
Jianxiang Ji, Sonja Dragojevic, Cameron M Callaghan, Emily J Smith, Surabhi Talele, Wenjuan Zhang, Margaret A Connors, Ann C Mladek, Zeng Hu, Katrina K Bakken, Paige P Sarkaria, Brett L Carlson, Danielle M Burgenske, Paul A Decker, Mohammad Abdur Rashid, Mi-Hyeon Jang, Shiv K Gupta, Jeanette E Eckel-Passow, William F Elmquist, Jann N Sarkaria
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts. Molecular cancer therapeutics 23 (5) (2024)
Jianxiang Ji, Sonja Dragojevic, Cameron M Callaghan, Emily J Smith, Surabhi Talele, Wenjuan Zhang, Margaret A Connors, Ann C Mladek, Zeng Hu, Katrina K Bakken, Paige P Sarkaria, Brett L Carlson, Danielle M Burgenske, Paul A Decker, Mohammad Abdur Rashid, Mi-Hyeon Jang, Shiv K Gupta, Jeanette E Eckel-Passow, William F Elmquist, Jann N Sarkaria
Differential distribution of the DNA-PKcs inhibitor peposertib selectively radiosensitizes patient-derived melanoma brain metastasis xenografts. Molecular cancer therapeutics (2024)
Jianxiang Ji, Sonja Dragojevic, Cameron M Callaghan, Emily J Smith, Surabhi Talele, Wenjuan Zhang, Margaret A Connors, Ann C Mladek, Zeng Hu, Katrina K Bakken, Paige P Sarkaria, Brett L Carlson, Danielle M Burgenske, Paul A Decker, Mohammad Abdur Rashid, Mi-Hyeon Jang, Shiv K Gupta, Jeanette E Eckel-Passow, William F Elmquist, Jann N Sarkaria
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts. Molecular cancer therapeutics 23 (5) (2024)
Jianxiang Ji, Sonja Dragojevic, Cameron M Callaghan, Emily J Smith, Surabhi Talele, Wenjuan Zhang, Margaret A Connors, Ann C Mladek, Zeng Hu, Katrina K Bakken, Paige P Sarkaria, Brett L Carlson, Danielle M Burgenske, Paul A Decker, Mohammad Abdur Rashid, Mi-Hyeon Jang, Shiv K Gupta, Jeanette E Eckel-Passow, William F Elmquist, Jann N Sarkaria
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts. Molecular cancer therapeutics 23 (5) (2024)
Jianxiang Ji, Sonja Dragojevic, Cameron M Callaghan, Emily J Smith, Surabhi Talele, Wenjuan Zhang, Margaret A Connors, Ann C Mladek, Zeng Hu, Katrina K Bakken, Paige P Sarkaria, Brett L Carlson, Danielle M Burgenske, Paul A Decker, Mohammad Abdur Rashid, Mi-Hyeon Jang, Shiv K Gupta, Jeanette E Eckel-Passow, William F Elmquist, Jann N Sarkaria
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts. Molecular cancer therapeutics 23 (5) (2024)
Wenjuan Zhang, Rachael Ann Vaubel, Ju-Hee Oh, Ann C Mladek, Surabhi Talele, Wenqiu Zhang, Katie L Waller, Danielle M Burgenske, Jann N Sarkaria, William F Elmquist
Delivery versus potency in treating brain tumors: BI-907828, a MDM2-p53 antagonist with limited BBB penetration but significant in vivo efficacy in glioblastoma. Molecular cancer therapeutics (2023)
Jessica I Griffith, Sneha Rathi, Wenqiu Zhang, Wenjuan Zhang, Lester R Drewes, Jann N Sarkaria, William F Elmquist
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors. Pharmaceutics 12 (12) (2020)